B
BIO
Bio Rad Labs Inc
314.46
-1.92-0.61%After Hours: 314.46 0.00 0.00%19:34 07/24 EDT
OPEN/PREV CLOSE316.48/316.38
TODAY RANGE311.66-317.13
VOL355.49K
MARKET CAP8.42B
52 WEEK RANGE236.73-343.12
AVG VOL (3M)390.03K
% TURNOVER1.33%
TURNOVER--
P/E (TTM)51.81
% RANGE1.67%
EPS(TTM)6.07
P/E(FORWARD)37.80
P/B1.231
BVPS255.37
DIVIDEND--
P/S3.286
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.73B
SHARES OUTSTANDING26.76M
NEXT EARNINGS07/29-08/03
FREE FLOAT18.22M
LOT SIZE1
EX-DATE03/08/2002
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Parnassus Value Equity Fund adds KO; exits BIO
Seeking Alpha·2d ago
Cyclosporiasis: Investing In Biosecurity
Simply Wall St·3d ago
Bio Rad Laboratories (BIO) Stock Looks Fairly Valued After A 57% Slide
Seeking Alpha·4d ago
Parnassus Value Equity Fund Q2 2026 Portfolio Review
Seeking Alpha·07/13 14:35
Longleaf Partners Fund exits BIO
Simply Wall St·07/12 00:30
Bio Rad Laboratories (BIO) Launches New ddPCR Kits Following A Fair Value Debate
Simply Wall St·07/02 21:34
What Bio-Rad Laboratories (BIO)'s Activist Pressure and Sartorius Stake Review Means For Shareholders
Seeking Alpha·07/02 05:33
Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential
Simply Wall St·06/28 17:09
Bio Rad Laboratories (BIO) Following ddPCR Expansion Narrative Looks Fully Valued
Dow Jones·06/26 11:30
S&P 500 Futures Drop In Premarket Trading; ON Semiconductor, DaVita Lag
Simply Wall St·06/18 18:25
How Stronger Results and Institutional Selling At Bio-Rad Laboratories (BIO) Has Changed Its Investment Story
Simply Wall St·06/11 13:21
Does New MicroVal Approval Clarify Bio-Rad (BIO)’s Competitive Edge in Food Safety Testing?